Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: Association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1

European Heart Journal

Volumn 30, Issue 7, 2009, Pages 840-849

  Mouquet, Frédéric ^a,b   Cuilleret, Franois ^a   Susen, Sophie ^a,b   Sautire, Karine ^a   Marboeuf, Philippe ^a   Ennezat, Pierre Vladimir ^a,b   McFadden, Eugne ^a   Pigny, Pascal ^a   Richard, Florence ^d   Hennache, Bernadette ^a   Vantyghem, Marie Christine ^a   Bertrand, Michel ^a   Dallongeville, Jean ^c   Jude, Brigitte ^a,b   Van Belle, Eric ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Angiogenesis; Collateral circulation; Coronary disease; Diabetes mellitus; Fibrinolysis; Insulin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADIPONECTIN; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COLLATERAL CIRCULATION; COLONY FORMING UNIT; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DISEASE ASSOCIATION; DISEASE DURATION; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; AGED; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; STEM CELLS;

EID: 64849103275     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn569     Document Type: Article

References (38)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
3. Koerselman J, van der Graaf Y, de Jaegere PP, Grobbee DE. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003;107:2507-2511.
4. Sobel BE. The metabolic syndrome vis-a-vis syndrome of insulin resistance: the perfect squall. Coron Artery Dis 2005;16:461-463.
5. Sobel BE, Woodcock-Mitchell J, Schneider DJ, Holt RE, Marutsuka K, Gold H. Increased plasminogen activator Inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence. Circulation 1998;97:2213-2221.
6. Xiang G, Schuster MD, Seki T, Kocher AA, Eshghi S, Boyle A, Itescu S. Down-regulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitors. J Exp Med 2004;200:1657-1666.
7. Olijhoek JK, Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der Graaf Y, Visseren FL. Presence of the metabolic syndrome does not impair coronary collateral vessel formation in patients with documented coronary artery disease. Diabetes Care 2005;28:683-689.
8. Koerselman J, de Jaegere PP, Verhaar MC, van der Graaf Y, Grobbee DE. High blood pressure Is inversely related with the presence and extent of coronary collaterals. J Hum Hypertens 2005;19:809-817.
9. Werner GS, Ferrari M, Betge S, Gastmann O, Richartz BM, Figulla HR. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 2001;104:2784-2790.
10. Cohen M, Sherman W, Rentrop KP, Gorlin R. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol 1989;13:297-303.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations In man. Diabetologia 1985;28:412-419.
12. Gibson CM, Ryan K, Sparano A, Moynihan JL, Rizzo M, Kelley M, Marble SJ, Laham R, Simons M, McClusky TR, Dodge JT Jr. Angiographic methods to assess human coronary angiogenesis. Am Heart J 1999;137:169-179.
13. Kundel HL, Polansky M. Measurement of observer agreement Radiology 2003;228:303-308.
14. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
15. Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, Finkel T. Endothelial progenitor cells as putative targets for angiostatin. Cancer Res 1999;59:5875-5877.
16. Vasa M, Fichtischerer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
17. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-293.
18. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM. Age-dependent impairment of angiogenesis. Circulation 1999;99:111-120.
19. Michaud SE, Menard C, Guy LG, Gennaro G, Rivard A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha/VEGF pathway. FASEB J 2003;17:1150-1152.
20. Losordo DW, Isner JM. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol 2001;21:6-12.
21. Fabre JE, Rivard A, Magner M, Silver M, Isner JM. Tissue inhibition of anglotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999;99:3043-3049.
22. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis In normocholesterolemic animals. Nat Med 2000;6:1004-1010.
23. Ilia R, Carmel S. Gueron M. Patients with coronary collaterals and normal left ventricular systolic function: clinical, hemodynamic, and angiographic characteristics. Angiology 1998;49:631-635.
24. Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis 2003;14:61-64.
25. Abaci A, Oguzhan A, Kahraman S, Eryol NK. Unal S, Arinc H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-2242.
26. Kilian JG, Keech A, Adams MR, Celermajer DS. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 2002;13:155-159.
27. Werner GS, Richartz BM, Heinke S, Ferrari M, Figulla HR. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 2003;24:1134-1142.
28. Melidonis A, Tournis S, Kouvaras G, Baltaretsou E, Hadanis S, Hajissavas I, Tsatsoulis A, Foussas S. Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol 1999;22:465-471.
29. Ilia R, Carmel S, Cafri C. Gueron M. Coronary collaterals in patients with normal and impaired left ventricular systolic function. Int J Cardiol 1998;63:151-153.
30. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999;154:355-363.
31. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation 2000;102:185-190.
32. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, Liu PL. Chen YL, Chen JW. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007;56:1559-1568.
33. He Z, Opland DM. Way KJ, Ueki K, Bodyak N, Kang PM, Izumo S, Kulkarni RN, Wang B, Liao R, Kahn CR, King GL. Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol 2006
34. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004;279:1304-1309.
35. Werner C, Kamani CH, Gensch C, Bohm M. Laufs U. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 2007;56:2609-2615.
36. McIlroy M, O'Rourke M. McKeown SR, Hirst DG, Robson T. Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1). Cordiovosc Res 2006;69:207-217.
37. Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol 2000;20:2019-2023.
38. Yamada T, Okamoto M, Sueda T, Hashimoto M, Kajiyama G. Relation between collateral flow assessed by Doppler guide wire and angiographic collateral grades. Am Heart J 1995;130:32-37.